Dihydropyrimidine dehydrogenase deficiency in patients with severe toxicity after 5-fluorouracil: a retrospective single-center study

BACKGROUND: 5-Fluorouracil (5-FU) is an agent frequently used in the treatment of solid cancers. A deficiency in the enzyme that catabolizes 5-FU leads to severe toxicity. The gene responsible for this enzyme is DPYD, located on chromosome 1q22. The most prevalent alteration described is DPYD*2A, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Detailleur, Stephanie, Segelov, Eva, Re, Marzia Del, Prenen, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774667/
https://www.ncbi.nlm.nih.gov/pubmed/33414624
http://dx.doi.org/10.20524/aog.2020.0551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774667/
https://www.ncbi.nlm.nih.gov/pubmed/33414624
http://dx.doi.org/10.20524/aog.2020.0551

Ejemplares similares